title: Pegylated interferon for hepatitis C virus infection in Down syndrome.
authors.affiliation: Department of Pediatrics, Juntendo University Graduate School of Medicine, Tokyo, Japan.
authors.forename: Mitsuyoshi
authors.initials: M
authors.lastname: Suzuki
authors.affiliation: Department of Pediatrics, Osaka General Medical Center, Osaka, Japan.
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Tajiri
authors.affiliation: Department of Pediatrics, Osaka General Medical Center, Osaka, Japan.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Takano
authors.affiliation: Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Yoko
authors.initials: Y
authors.lastname: Miyoshi
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D004314:Down Syndrome / Q000188:drug therapy; D004359:Drug Therapy, Combination; D016174:Hepacivirus; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D007372:Interferons